← Leaderboards
Xiao-Fan Wang
Duke University
$23,927,835
Attributed
$26,423,286
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,423,286 · 18
By mechanism
R01$22,148,062 · 15
T32$3,529,516 · 1
R21$745,708 · 2
Top collaborators
- Qijing Li7 shared
- Tso-Pang Yao5 shared
Most similar at Duke University
Same institution · by research overlap
- Tso-Pang Yao$7,963,781
- Timothy R. Degrado$3,088,064
- Julia K L Walker$6,460,748
- Qijing Li$4,973,474
- Christopher Mosher$565,000
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingMolecularPathway InteractionsResponseMalignant NeoplasmsTumorigenesisTumorSignal PathwaySignal TransductionBaseCancer TherapyNeoplastic CellMouse ModelCancer CellRegulationGrowthCell AgingCytokineChemokinePlayNovel TherapeuticsGenesFoundations
Grant awards (82)
Roles of mitochondrial dynamics and mtDNA in senescence$390,464
R01 · FY2025 · GM
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma$486,559
R01 · FY2024 · CA · contact PI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.$464,562
R01 · FY2024 · CA · contact PI
Roles of mitochondrial dynamics and mtDNA in senescence$390,599
R01 · FY2024 · GM
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma$494,541
R01 · FY2023 · CA · contact PI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.$478,350
R01 · FY2023 · CA · contact PI
Targeting UHRF1 in combinational immunotherapy$461,025
R01 · FY2023 · CA · contact PI
Roles of mitochondrial dynamics and mtDNA in senescence$390,647
R01 · FY2023 · GM
Roles of mitochondrial dynamics and mtDNA in senescence$103,752
R01 · FY2023 · GM
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma$494,201
R01 · FY2022 · CA · contact PI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.$480,907
R01 · FY2022 · CA · contact PI
Targeting UHRF1 in combinational immunotherapy$461,315
R01 · FY2022 · CA · contact PI
Roles of mitochondrial dynamics and mtDNA in senescence$390,761
R01 · FY2022 · GM
Synthetic lethality by targeting the core senescent mechanism in lung cancer.$490,590
R01 · FY2021 · CA · contact PI
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma$469,848
R01 · FY2021 · CA · contact PI
Targeting UHRF1 in combinational immunotherapy$468,277
R01 · FY2021 · CA · contact PI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.$497,781
R01 · FY2020 · CA · contact PI
Targeting UHRF1 in combinational immunotherapy$468,148
R01 · FY2020 · CA · contact PI
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma$456,286
R01 · FY2020 · CA · contact PI
Targeting UHRF1 in combinational immunotherapy$473,749
R01 · FY2019 · CA · contact PI
The Roles of MicroRNAs in Glioblastoma$317,398
R01 · FY2016 · CA · contact PI
The anti-senescence activity of trefoil factor 1$316,621
R01 · FY2016 · CA · contact PI
The Roles of MicroRNAs in Glioblastoma$317,398
R01 · FY2015 · CA · contact PI
The anti-senescence activity of trefoil factor 1$316,888
R01 · FY2015 · CA · contact PI
Molecular determinants underlying herceptin sensitivity and resistance$207,495
R21 · FY2015 · CA · contact PI
Cancer Biology Training Grant$431,898
T32 · FY2014 · CA · contact PI
The Roles of MicroRNAs in Glioblastoma$307,876
R01 · FY2014 · CA · contact PI
The anti-senescence activity of trefoil factor 1$307,633
R01 · FY2014 · CA · contact PI
The role of TGF-beta in tumorigenesis$302,121
R01 · FY2014 · CA · contact PI
Molecular determinants underlying herceptin sensitivity and resistance$170,738
R21 · FY2014 · CA · contact PI
Cancer Biology Training Grant$390,186
T32 · FY2013 · CA · contact PI
The Roles of MicroRNAs in Glioblastoma$298,355
R01 · FY2013 · CA · contact PI
The anti-senescence activity of trefoil factor 1$298,354
R01 · FY2013 · CA · contact PI
The role of TGF-beta in tumorigenesis$292,902
R01 · FY2013 · CA · contact PI
Cancer Biology Training Grant$417,668
T32 · FY2012 · CA · contact PI
The anti-senescence activity of trefoil factor 1$317,642
R01 · FY2012 · CA · contact PI
The Roles of MicroRNAs in Glioblastoma$317,398
R01 · FY2012 · CA · contact PI
The role of TGF-beta in tumorigenesis$311,725
R01 · FY2012 · CA · contact PI
Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer$193,797
R21 · FY2012 · CA · contact PI
Cancer Biology Training Grant$368,220
T32 · FY2011 · CA · contact PI
The role of TGF-beta in tumorigenesis$311,849
R01 · FY2011 · CA · contact PI
Mechanisms of TGF-B/Smad Signaling$290,502
R01 · FY2011 · GM · contact PI
Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer$173,678
R21 · FY2011 · CA · contact PI
Cancer Biology Training Grant$402,732
T32 · FY2010 · CA · contact PI
The role of TGF-beta in tumorigenesis$321,452
R01 · FY2010 · CA · contact PI
Mechanisms of TGF-B/Smad Signaling$293,436
R01 · FY2010 · GM · contact PI
TGFBI and tumorigenesis$268,871
R01 · FY2010 · CA · contact PI
Rad17 - & p53-mediated apoptosis pathways in response to DNA damage$268,871
R01 · FY2010 · CA · contact PI
Cancer Biology Training Grant$360,860
T32 · FY2009 · CA · contact PI
Mechanisms of TGF-B/Smad Signaling$296,400
R01 · FY2009 · GM · contact PI
Rad17 - & p53-mediated apoptosis pathways in response to DNA damage$268,871
R01 · FY2009 · CA · contact PI
TGFBI and tumorigenesis$268,871
R01 · FY2009 · CA · contact PI
Cancer Biology Training Grant$393,729
T32 · FY2008 · CA · contact PI
Mechanisms of TGF-B/Smad Signaling$296,400
R01 · FY2008 · GM · contact PI
Rad17 - & p53-mediated apoptosis pathways in response to DNA damage$268,871
R01 · FY2008 · CA · contact PI
TGFBI and tumorigenesis$268,871
R01 · FY2008 · CA · contact PI
Cancer Biology Training Grant$388,547
T32 · FY2007 · CA · contact PI
Rad17 - & p53-mediated apoptosis pathways in response to DNA damage$268,871
R01 · FY2007 · CA · contact PI
TGFBI and tumorigenesis$268,871
R01 · FY2007 · CA · contact PI
TGF-beta Signaling in MSCs and Osteoblast$240,203
R01 · FY2007 · DK · contact PI
Cancer Biology Training Grant$375,676
T32 · FY2006 · CA · contact PI
Analysis of Rad17-mediated Checkpoint Signaling$301,138
R01 · FY2006 · CA · contact PI
TGFBI and tumorigenesis$291,160
R01 · FY2006 · CA · contact PI
Rad17 - & p53-mediated apoptosis pathways in response to DNA damage$284,087
R01 · FY2006 · CA · contact PI
TGF-beta Signaling in MSCs and Osteoblast$247,376
R01 · FY2006 · DK · contact PI
Analysis of Rad17-mediated Checkpoint Signaling$60,684
R01 · FY2006 · CA · contact PI
Analysis of Rad17-mediated Checkpoint Signaling$308,385
R01 · FY2005 · CA
TGF-beta Signaling in MSCs and Osteoblast$253,330
R01 · FY2005 · DK
Analysis of Rad17-mediated Checkpoint Signaling$59,096
R01 · FY2005 · CA
Analysis of Rad17-mediated Checkpoint Signaling$308,385
R01 · FY2004 · CA
TGF-beta Signaling in MSCs and Osteoblast$253,330
R01 · FY2004 · DK
Analysis of Rad17-mediated Checkpoint Signaling$48,989
R01 · FY2004 · CA
Analysis of Rad17-mediated Checkpoint Signaling$308,385
R01 · FY2003 · CA
ANALYSIS OF THE FUNCTIONAL ROLE OF TPE IN TUMORIGENESIS$277,200
R01 · FY2003 · CA
Analysis of Rad17-mediated Checkpoint Signaling$308,385
R01 · FY2002 · CA
TUMOR SUPPRESSOR SMADS AND TGF-BETA SIGNALING$299,239
R01 · FY2002 · CA
ANALYSIS OF THE FUNCTIONAL ROLE OF TPE IN TUMORIGENESIS$277,200
R01 · FY2002 · CA
TUMOR SUPPRESSOR SMADS AND TGF-BETA SIGNALING$290,432
R01 · FY2001 · CA
ANALYSIS OF THE FUNCTIONAL ROLE OF TPE IN TUMORIGENESIS$277,200
R01 · FY2001 · CA
TUMOR SUPPRESSOR SMADS AND TGF-BETA SIGNALING$280,878
R01 · FY2000 · CA
ANALYSIS OF THE FUNCTIONAL ROLE OF TPE IN TUMORIGENESIS$277,200
R01 · FY2000 · CA
TGF-BETA SIGNALING PATHWAY AND CELL GROWTH REGULATION$100,100
R01 · FY2000 · DK